Dracen Pharmaceuticals announces two presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

San Diego, CA (PRWEB) April 08, 2022 -- Dracen Pharmaceuticals Inc., a clinical stage biotech company developing anti-cancer drugs that target

Related Keywords

New York ,United States ,Louisiana ,New Orleans ,Deerfield ,San Diego ,California ,Prague ,Praha ,Hlavníesto ,Czech Republic ,University Of California San Diego ,American ,Robert Wild ,Michael Allevato ,Institute Of Organic Chemistry ,Osage University Partners ,Dracen Pharmaceuticals Inc ,American Association For Cancer Research ,Grossman School Of Medicine ,Department Of Pathology ,Biotech Fund ,Convention Center ,Dracen Pharmaceuticals ,Perlmutter Cancer Center ,Pharmaceuticals Inc ,American Association ,Cancer Research ,Annual Meeting ,Thales Papagiannakopoulos ,Associate Professor ,Perlmutter Cancer ,Metabolic Requirements ,California San Diego ,Deerfield Management ,Norganic Chemistry ,Press Release ,